We present a series of 15 cases of molecularly confirmed ES, trying to find the meaning of its immunoreactivity for CD99 and PAX8, to determine whether there is enough sensitivity to be useful in the diagnosis of these tumours. This evidence concerns the gene CD99 and neoplasm.